Royal Bank of Canada
PHIO icon

Royal Bank of Canada’s Phio Pharmaceuticals PHIO Stock Holding History

Royal Bank of Canada’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,464
Closed -$8K – 7414
2025
Q2 		$8K Buy
+3,464
New +$7.01K ﹤0.01% 6542
2018
Q1 		– Hold
0
– – – 6683
2017
Q4 		– Hold
0
– – – 6795
2017
Q3 		– Hold
0
– – – 6913
2014
Q2 		– Hold
0
– – – 6084
2014
Q1 		– Hold
0
– – – 6085

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada's PHIO Position: Q3 2025 in Review

Royal Bank of Canada sold out of Phio Pharmaceuticals (PHIO) in Q3 2025, closing a stake of 3,464 shares — an estimated $8K sold.

Royal Bank of Canada first reported a position in PHIO in Q2 2025 and held it in 1 quarter. The position peaked at $8K in Q2 2025. 11 funds tracked by Wall St. Rank hold PHIO as of Q3 2025.

  • Royal Bank of Canada reported no remaining Phio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 3,464 Phio Pharmaceuticals shares in Q3 2025, an estimated $8K.
  • Royal Bank of Canada first reported a position in Phio Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Royal Bank of Canada's Phio Pharmaceuticals position peaked at $8K in Q2 2025.
  • 11 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.